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Despite the fact that pheochromocytomas  are rela- 
tively rare, occurring in approximately 2 of  100,000 
adults, they are important because they can be 
diagnosed with great accuracy if suspected and are 
usually fatal if not detected and appropriately man- 
aged [1]. In 90% of  primary cases, modern manage- 
ment results in a successful outcome with cure of 
the patient. Brennan and Keiser  in the present 
report relate their experience in managing a small 
but important group of patients in which the initial 
operation failed, either because an ectopic tumor 
was not found, the tumor was malignant or there 
were multiple tumors present.  They also emphasize 
that aggressive surgical treatment of malignant 
pheochromocytomas  in conjunction with adrener- 
gic blocking agents may result in some long-term 
survivals. 
One preventable cause of  persistent or recurrent  
pheochromocytoma is the failure to excise both 
adrenal glands in patients with MEA tI syndromes.  
When adrenal medullary disease is present in the 
MEA II syndrome, it is always bilateral [2-4]. In 
some patients, however ,  the adrenal contralateral 
to one with an obviously palpable tumor may show 
only medullary hyperplasia (the precursor  to the 
development of  pheochromocy toma  in these syn- 
dromes). Any at tempt to leave functioning adrenal 
tissue will inevitably result in recurrence.  Our expe- 
rience is in complete agreement  with that at the 
Mayo Clinic where they have concluded that total 
adrenalectomy is the treatment of  choice in patients 
when the adrenal component  of  the MEA  II syn- 
drome has been diagnosed [1, 4]. Scintigraphy of 
the adrenal medulla using 1131 metaiodobenzylguan- 
idine (MIBG) has recently demonstrated that bilat- 
eral adrenal medullary hyperplasia can be diag- 
nosed at a very  early stage before biochemical 
evidence of hyperplasia or pheochromocy toma  is 
diagnostic [5]. Of 6 MEA II family members  who 
were found to have the adrenal component  of  the 
syndrome by MIBG scanning, none had CT scan 
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evidence of adrenal disease. At operation, all 6 
patients had either adrenal medullary hyperplasia or 
pheochromocytomas less than a centimeter in diam- 
eter. Although it is controversial as to when these 
asymptomatic patients should undergo bilateral ad- 
renalectomy, it is further evidence that bilateral 
changes are present even when the adrenal glands 
appear normal. 
The authors utilized CT scanning as their first 
localizing study just as they would in patients 
undergoing localization for primary explorations. 
Currently CT should be considered the best means 
of localizing a pheochromocytoma. Utilizing pres- 
ent generation CT scanners, more than 90% of 
adrenal pheochromocytomas can be identified [1]. 
Invasive localization studies including selective 
aortography and selective venous sampling for cate- 
cholamines are no longer needed in most primary 
cases. Although CT scanning is accurate in demon- 
strating pheochromocytomas arising from the adre- 
nal glands, this technique has been less successful 
in identifying extra-adrenal tumors. The authors 
have utilized both selective arteriography and selec- 
tive venous sampling in these circumstances. Inva- 
sive localization studies should be performed only 
after the patients have been blocked with alpha 
adrenergic agents. Despite the benefit of all 3 types 
of localization procedures, some pheochromocyto- 
mas will not be identified [6, 7]. Furthermore, false/ 
positive localization may result from the interpreta- 
tion of both CT and venous sampling studies. This 
is less likely with aortography when a definite 
tumor blush has been seen. Unfortunately, some 
extra-adrenal tumors may not be sufficiently vascu- 
lar to be identified by this method. 
Since August, 1980, we have utilized I ~3~ MIBG 
for localization of pheochromocytomas in all pa- 
tients in whom this disease was strongly suspected 
on the basis of biochemical studies. The preliminary 
results with this agent showed that even small 
extra-adrenal pheochromocytomas as well as malig- 
nant tumors and their metastases could be demon- 
strated [8]. More than 40 patients with surgically 
proven pheochromocytomas have now been evalu- 
ated. Only 3 pheochromocytomas were not demon- 
strated by scintigraphy within 48 hours following 
the administration of this agent. The 3 tumors which 
failed to image were all solitary, extra-adrenal tu- 
mors located in the right renal hilum. Two were 
subsequently localized by selective arteriography 
and the other by CT scan. With the exception of 
primary tumors within the adrenal gland, CT scans 
and selective venous sampling were frequently neg- 
ative or misleading in the other cases. Fourteen 
patients had malignant pheochromocytomas. Some 
of these patients had multiple metastases to lymph 
nodes, liver, lungs and bone which were readily 
demonstrated by I TM MIBG. Extra-adrenal pheo- 
chromocytomas were successfully imaged in 7 pa- 
tients whose lesions were apparently benign. Three 
local recurrences, believed caused by previous op- 
erative implantation, were also identified by this 
method. At present, 5 patients with metastatic 
pheochromocytomas have received therapeutic 
doses of I TM MIBG. We are encouraged by the 
preliminary results, although it is too early to deter- 
mine whether this will be the most effective means 
of managing malignant lesions not amenable to 
surgical extirpation. For localization, however, we 
consider 113~ MIBG to be the most accurate tech- 
nique for identifying extra-adrenal, malignant or 
recurrent pheochromocytomas. Furthermore, even 
when CT scanning is positive in demonstrating a 
mass, it does not verify its function which I j3~ 
MIBG does. Also scintigraphy may identify occult 
metastases in patients unsuspected of having a 
malignancy. Finally, some patients with adrenal 
primary tumors also have synchronous benign ex- 
tra-adrenal tumors which can be a cause of persist- 
ent disease if unrecognized. It is hoped that I TM 
MIBG imaging will appreciably decrease the occur- 
rence of failed operations for pheochromocytomas 
in the future. This agent will be available for multi- 
center evaluation during this year. 
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